Medical Services Advisory Committee - Applications considered
- 1546.1 - Abdominoplasty with repair of rectus diastasis (also known as rectus divarication) following pregnancy
- 1564 - Review of immunoglobulin use for Chronic Inflammatory Demyelinating Polyneuropathy
- 1578 - Arthroscopic injection of a bioadhesive hydrogel implant (JointRep™) in conjunction with microfracture for treatment of osteochondral defects of the knee
- 1585 - Genetic testing for the diagnosis of early-onset or familial neuromuscular disorders
- 1628 - Alpha-1-Antitrypsin genotyping
- 1631 - Home sleep apnoea test utilizing peripheral arterial tone
- 1632 - PSMA PET/CT imaging for informing treatment of patients with prostate cancer
- 1635 - Transcatheter aortic valve implantation via transfemoral delivery using the balloon-expandable valve system for patients at low risk for surgery
- 1640 - Transcatheter aortic valve implantation (TAVI) via transfemoral delivery for patients at low risk for surgery
- 1647 - Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma
- 1651 - Integrated, closed-system, extracorporeal photopheresis systems for the treatment of chronic graft-versus-host disease
- 1663 - Review of Continuous Glucose Monitoring (CGM) products provided through the CGM Initiative
- 1676 - Amendments to eligibility criteria for tisagenlecleucel for treatment of relapsed or refractory diffuse large B-cell lymphoma – amend clinical criteria for patients with Transformed Follicular Lymphoma (TFL) and propose inclusion of patients with grade 3B follicular lymphoma (3B FL)
- Gene Expression Profiling Tests - EndoPredict®, MammaPrint®, Prosigna®